Olivier Douliery / AFP / Getty
- MiMedx Group, a biopharmaceutical company, received $10 million from the government's Paycheck Protection Program two weeks after paying the government $6.5 million to resolve allegations it had been knowingly overcharging for medical supplies.
- Last year the company was also sued for exaggerating its revenue to investors. That case was settled and no fault was admitted. Two of its executives were also indicted on accounting fraud charges.
- Hilary Dixon, a MiMedx spokesperson, told The New York Times: "We don't have the option of raising capital in the public markets owing to our financial restatement process."
- The government's Paycheck Protection Program is a core part of the Trump administration's attempts to protect the economy from the impact of restrictions and social distancing.
- Visit Business Insider's homepage for more stories
A biopharmaceutical company received $10 million from the government's Paycheck Protection Program two weeks after paying the government $6.5 million to resolve Justice Department allegations that it had been knowingly overcharging for medical supplies.
On April 6, MiMedx Group, which makes and sells human tissue grafts and is based in Georgia, agreed to pay $6.5 million to resolve a Justice Department investigation that alleged it had violated federal law by knowingly overcharging the Department of Veterans Affairs for medical supplies, according to The New York Times.
See the rest of the story at Business Insider
NOW WATCH: Inside London during COVID-19 lockdown
See Also:
- Hotel conglomerate owned by a Trump mega-donor that scooped up the most coronavirus bailout loans says it has no plans to return the money
- Trump flip-flopped over Georgia's decision to reopen the state, but the president's supporters there don't seem to mind
- Trump wants the US Navy to destroy Iranian gunboats that harass US ships. Here's why it doesn't do that.
from Business Insider https://ift.tt/2y4UE1o
No comments:
Post a Comment